Sinotau Pharmaceutical Group
Clinical trials sponsored by Sinotau Pharmaceutical Group, explained in plain language.
-
Radioactive injection targets advanced neuroendocrine tumors in new trial
Disease control OngoingThis study is testing whether a radioactive drug injection can safely control advanced neuroendocrine cancer that has progressed despite other treatments. The trial involves 74 adults with inoperable, spreading tumors that have specific markers. Participants receive the injection…
Phase: PHASE2, PHASE3 • Sponsor: Sinotau Pharmaceutical Group • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Radioactive drug trial offers new hope for advanced neuroendocrine cancer patients
Disease control OngoingThis study compared a new radioactive drug treatment to standard therapy for people with advanced neuroendocrine tumors of the digestive system that had stopped responding to previous treatment. The trial involved 196 participants whose cancer had progressed despite standard care…
Phase: PHASE3 • Sponsor: Sinotau Pharmaceutical Group • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC